Evaluate the Safety and Efficacy of HL-1186 Tablet for Moderate to Severe Acute Pain After Surgery

Clinical trial NCT07147049 · RECRUITING

Trial details

NCT number: NCT07147049
Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate to Severe Acute Postoperative Pain

Start date: 2025-08-08
Primary completion: 2025-12-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.